Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1α is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML)

Stem Cells

Volumn 19, Issue 4, 2001, Pages 321-328

  Karlic, H ^a,d   Louda, N ^a,b   Pfeilstocker M ^a   Keil, F ^b   Lohninger, A ^b   Pittermann, E ^a   Paukovits, J ^c  

^a HANUSCH HOSPITAL   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Institute for Leukemia Research   (Austria)

Author keywords

Chronic myeloid leukemia; Hemoregulatory peptide; Long term bone marrow cultures; MIP 1

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BCR ABL PROTEIN; CARNITINE PALMITOYLTRANSFERASE; CD34 ANTIGEN; GENE PRODUCT; HEMOREGULATORY PENTAPEPTIDE 5B; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PHOSPHOLIPASE A2; PROTEIN G ALPHA16; REGULATOR PROTEIN; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CULTURE; CANCER CELL; CELL GROWTH; CHRONIC MYELOID LEUKEMIA; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISULFIDE BOND; ENZYME METABOLISM; ERYTHROID CELL; GENE EXPRESSION REGULATION; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MACROPHAGE; MEGAKARYOCYTE; OXIDATION REDUCTION REACTION; PHILADELPHIA 1 CHROMOSOME; PROTEIN ANALYSIS; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

EID: 0034901057     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.19-4-321     Document Type: Article

References (37)

1. Isolation and synthesis of a hemoregulatory peptide
2. The hematopoiesis specific G protein alpha subunit Gα16 is a marker of early normal and malignant hematopoiesis
3. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: Synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma
4. Monitoring of hematopoietic recovery after autologous stem cell transplantation by analysis of G alpha 16 mRNA and CD34 surface glycoprotein
5. Expression of Gα16, a G protein α subunit specific for hematopoiesis in acute leukemia
6. In vivo and in vitro effects of cytokines and the hemoregulatory peptide dimer (pEEDCK)2 on Gα16 positive hematopoiesis
7. Protection from arabinofuranosylcysteine (ara-C) and N-mustard induced myelotoxicity using hemoregulatory peptide (pGlu-Glu-Asp-Cys-Lys, pEEDCK) monomer and dimer
8. The dimer of hemoregulatory peptide (HP5b) stimulates murine and human myelopoiesis in vitro
9. Regulation of colony stimulating activity production from bone marrow stromal cells by the hemoregulatory peptide HP-5b
10. The active monomeric forro of macrophage inflammatory protein-1α interacts with high- and low-affinity classes of receptors on human hematopoietic cells
11. Hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys: A new synthetic derivative for avoiding dimerization and loss of inhibitory activity
12. The LightCycler: A microvolume multisample fluorimeter with rapid temperature control
13. Stem cell stimulation in vitro by the dekapeptide (pEEDCK)2: A single factor alternative for multifactor cocktails
14. The myelostimulatory dekapeptide (pEEDCK) induces proliferation in pluripotent hemopoietic stem cells in vivo and increases leukocyte and platelet production: A possible alternative for recombinant hemopoietic growth factors
15. Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia
16. Bone marrow transplantation for chronic myelogenous leukemia
17. Effect of interleukin-3, stem cell factor and granulocyte macrophage colony stimulating factor on committed stem cells, long term culture initiating cells (LTC-IC) and bone marrow stroma in a one step long term bone marrow culture (LTBMC)
18. Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3
19. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis
20. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme
21. Fatty acid import into mitochondria
22. Carnitine deficiency causes downregulation of the carnitine acyltransferase genes
23. Über den Stoffwechsel der Carcinomzelle (on metabolism of carcinoma cell, German)
24. Intermediary metabolism of fast-growth tumor cells
25. Leukemic cell creatine kinase and its isoenzymes
26. The hexose transport system in the human K-562 chronic myelogenous leukemia-derived cell
27. Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia
28. Is absence of pyruvate complex in mitochondria a possible explanation of significant aerobic glycolysis by normal human leukocytes?
29. The role of the redox protein thioredoxin in cell growth and cancer
30. The hemoregulatory peptide pEEDCK may inhibit stem cell proliferation via hydropathical binding to antisense sequence motifs in interleukin 11 and other growth factors
31. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia
32. Appropriate controls for RT-PCR, commentary
33. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro
34. G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells
35. Diverse expression of cytosolic phospholipase A2, 5-lipoxygenase and prostaglandin H synthase 2 in acute pre-B-lymphocytic leukaemia cells
36. Role of the KIT protooncogene in normal and malignant human hematopoiesis
37. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction